Choroidal Neovascularization Market

Choroidal neovascularization?describes the growth of new blood vessels that originate from the?choroid?through a break in the Bruch membrane into the sub?retinal pigment epithelium (sub-RPE) or subretinal space.

Scope of the Report:

Choroidal Neovascularization Market focuses on the Choroidal Neovascularization in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. Choroidal Neovascularization Market categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Choroidal Neovascularization is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2027, from xx million US$ in 2021, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, Choroidal Neovascularization Market covers

Pfizer Inc.

F. Hoffmann-La Roche Ltd.

Novartis AG

Regeneron Pharmaceuticals Inc.

Bayer AG

QLT Inc.

Sanwa Kagaku Kenkyusho Co. Ltd.

Promedior Inc.

Valeant Pharmaceuticals International Inc.

Gilead Sciences Inc

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Intravenous

Intravitreal

Market Segment by Applications, can be divided into

Extreme Myopia

Malignant Myopic Degeneration

Age-Related Developments

There are 15 Chapters to deeply display the global Choroidal Neovascularization market.

Chapter 1, to describe Choroidal Neovascularization Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Choroidal Neovascularization, with sales, revenue, and price of Choroidal Neovascularization, in 2016 and 2021;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2021;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Choroidal Neovascularization, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Choroidal Neovascularization market forecast, by regions, type and application, with sales and revenue, from 2018 to 2027;

Chapter 13, 14 and 15, to describe Choroidal Neovascularization sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source